切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2025, Vol. 19 ›› Issue (02) : 248 -249. doi: 10.3877/cma.j.issn.1674-3253.2025.02.021

病例报告

原发性肾血管肉瘤并出血一例报告并文献复习
汪洋1, 张楠1, 杨伟锋1, 何海填1, 王可兵,1   
  1. 1. 518000 广东,深圳市前海蛇口自贸区医院泌尿外科
  • 收稿日期:2023-08-23 出版日期:2025-04-01
  • 通信作者: 王可兵

Primary renal angiosarcoma complicated with hemorrhage: a case report and literature review

Yang Wang1, Nan Zhang1, Weifeng Yang1, Haitian He1, Kebing Wang,1   

  1. 1. Department of Urology,Qianhai Shekou Free Trade Zone Hospital,Shenzhen 518000,China
  • Received:2023-08-23 Published:2025-04-01
  • Corresponding author: Kebing Wang
引用本文:

汪洋, 张楠, 杨伟锋, 何海填, 王可兵. 原发性肾血管肉瘤并出血一例报告并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 248-249.

Yang Wang, Nan Zhang, Weifeng Yang, Haitian He, Kebing Wang. Primary renal angiosarcoma complicated with hemorrhage: a case report and literature review[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2025, 19(02): 248-249.

目的

探讨原发性肾血管肉瘤(PRA)的临床表现、诊治及预后。

方法

回顾性分析1 例原发性肾血管肉瘤并出血、全身多处转移患者的临床资料,结合文献复习,对该病进行讨论。

结果

本例患者因“突发左侧腰腹部胀痛5 h”入院,CT 提示左肾肿瘤并出血、全身多处转移,该患者在全麻下行开放左肾姑息性切除术,病理结果证实为左肾血管肉瘤,术后予以化疗、靶向及免疫等全身综合治疗,治疗中患者病情稳定,3 个疗程后患者因经济原因放弃继续治疗,术后1 年死亡。

结论

原发性肾血管肉瘤临床罕见,侵袭性强,预后差,确诊主要依据病理,治疗首选根治性肾切除术,术后应辅以化疗、放疗。靶向及免疫治疗或许是PRA 的有效治疗方法。

Objective

To investigate the clinical characteristics,treatment and prognosis of primary renal angiosarcoma (PRA).

Methods

One case of primary renal angiosarcoma complicated with hemorrhage and multiple systemic metastases was retrospectively analysed and relevant literatures were reviewed.

Results

The patient was admitted to our hospital for “acute left abdominal pain for 5 hours”,CT revealed a tumor in his left kidney complicated with hemorrhage,palliative left nephrectomy was performed and pathologic diagnosis confirmed renal angiosarcoma,though chemotherapy,targeted therapy and immunotherapy were carried out.The patient's condition was stable during treatment.After 3 courses of comprehensive treatment,the patient gave up for economic reasons,and dead one-year after operation.

Conclusions

Primary renal angiosarcoma is an exceedingly rare and highly aggressive neoplasm with a poor prognosis,the final diagnosis depends on pathology.Once diagnosed,radical nephrectomy should be performed early,chemotherapy and radiotherapy should be followed after surgery,targeted therapy and immunotherapy may be effective treatments for PRA.

图1 原发性肾血管肉瘤患者术前影像学资料 图2 患者左肾及肿瘤大体标本 图3 患者肿瘤病理免疫组化结果
[1]
Kress GH.Concerning a letter to past presidents of the California medical association and reply thereto[J].Cal West Med,1942,56(5):331.
[2]
Kazaz IO,Ersoz S,Colak F,et al.Primary renal angiosarcoma: a case report and a short review of literature[J].Indian J Pathol Microbiol,2020,63(Supplement): S44-S46.DOI: 10.4103/IJPM.IJPM_66_19.
[3]
Subramanian H,Parepalli D,Srinivas BH,et al.Primary renal angiosarcoma with lymph node metastasis- a rare intriguing malignancy with a grim outcome[J].Urology,2021,153: 14-16.DOI:10.1016/j.urology.2021.02.016.
[4]
Omiyale AO.Clinicopathological features of primary angiosarcoma of the kidney: a review of 62 cases[J].Transl Androl Urol,2015,4(4): 464-473.DOI: 10.3978/j.issn.2223-4683.2015.05.04.
[5]
陈丹玉,杨锦建,罗彬杰,等.原发性肾血管肉瘤的临床特点及预后影响因素分析[J].河南外科学杂志,2019,25(1): 21-24.DOI:10.16193/j.cnki.hnwk.2019.01.008.Chen DY,Yang JJ,Luo BJ,et al.Clinical characteristic and influencing factors of prognosis of primary angiosarcoma of kidney[J].Henan J Surg,2019,25(1): 21-24.DOI: 10.16193/j.cnki.hnwk.2019.01.008.
[6]
Omiyale AO,Carton J.Clinical and pathologic features of primary angiosarcoma of the kidney[J].Curr Urol Rep,2018,19(2): 4.DOI:10.1007/s11934-018-0755-6.
[7]
Iacovelli R,Orlando V,Palazzo A,et al.Clinical and pathological features of primary renal angiosarcoma[J].Can Urol Assoc J,2014,8(3-4): E223-E226.DOI: 10.5489/cuaj.1585.
[8]
Zhou J,Yang X,Zhou L,et al.Anastomosing hemangioma incidentally found in kidney or adrenal gland: study of 10 cases and review of literature[J].Urol J,2020,17(6): 650-656.DOI: 10.22037/uj.v0i0.5514.
[9]
Fukunaga M.Angiosarcoma of the kidney with minute clear cell carcinomas: a case report[J].Pathol Res Pract,2009,205(5): 347-351.DOI: 10.1016/j.prp.2008.11.005.
[10]
Chang CW,Chien CC,Juan YS,et al.Primary renal angiosarcoma mimicking urothelial carcinoma-a case report and literature reviews[J].Urol Case Rep,2021,34: 101407.DOI: 10.1016/j.eucr.2020.101407.
[11]
Omiyale AO.Primary vascular tumours of the kidney[J].World J Clin Oncol,2021,12(12): 1157-1168.DOI: 10.5306/wjco.v12.i12.1157.
[12]
Komoto H,Kitajima K,Kawanaka Y,et al.CT findings of primary renal angiosarcoma[J].Case Rep Oncol,2021,14(1): 212-216.DOI:10.1159/000512015.
[13]
Heo SH,Shin SS,Kang TW,et al.Primary renal angiosarcoma with extensive hemorrhage: CT and MRI findings[J].Int Braz J Urol,2019,45(2): 402-405.DOI: 10.1590/S1677-5538.IBJU.2018.0375.
[14]
Waqas M,Rahim W,Shohab D,et al.Primary renal epithelioid angiosarcoma[J].J Coll Physicians Surg Pak,2018,28(3): S66-S68.DOI: 10.29271/jcpsp.2018.03.S66.
[15]
周祥福,周琦,张涛,等.原发性肾血管肉瘤一例报告并文献复习[J/OL].中华腔镜泌尿外科杂志(电子版),2009,3(5): 393-397.DOI: 10.3969/j.issn.1674-3253.2009.05.005.Zhou XF,Zhou Q,Zhang T,et al.Case report of renal angiosarcoma and review of the literature[J/OL].Chin J Endourol Electron Ed,2009,3(5): 393-397.DOI: 10.3969/j.issn.1674-3253.2009.05.005.
[16]
Celebi F,Pilanci KN,Saglam S,et al.Primary renal angiosarcoma with progressive clinical course despite surgical and adjuvant treatment: a case report[J].Oncol Lett,2015,9(4): 1937-1939.DOI:10.3892/ol.2015.2902.
[17]
Zhang C,Xu G,Liu Z,et al.Epidemiology,tumor characteristics and survival in patients with angiosarcoma in the United States: a population-based study of 4537 cases[J].Jpn J Clin Oncol,2019,49(12): 1092-1099.DOI: 10.1093/jjco/hyz113.
[18]
Darlington D,Anitha FS.Primary renal angiosarcoma mimicking renal cell carcinoma: a case report[J].Cureus,2019,11(1): e3841.DOI: 10.7759/cureus.3841.
[19]
Zenico T,Saccomanni M,Salomone U,et al.Primary renal angiosarcoma: case report and review of world literature[J].Tumori,2011,97(4): e6-9.DOI: 10.1177/030089161109700422.
[20]
Agulnik M,Yarber JL,Okuno SH,et a1.An open-label,multicenter,phase Ⅱstudy of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas[J].Ann Oneol,201,24(1): 257-26.
[21]
Celebi F,Pilanci KN,Saglam S,et al.Primary renal angiosarcoma with progressive clinical course despite surgical and adjuvant treatment: a case report[J].Oncol Lett,2015,9(4): 1937-1939.DOI:10.3892/ol.2015.2902.
[1] 朱亿豪, 杨飞亚, 管考鹏, 李旭文, 翟亚博, 叶雄俊. 机器人辅助腹腔镜下右肾门后唇肿瘤保留肾单位手术[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 278-278.
[2] 吴卓龙, 陈琼, 王荀, 孔文, 黄吉炜. 零缺血免缝合微波辅助机器人肾脏肿瘤剜除技术(MIRACLE 技术)在肾门部肿瘤保肾手术中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 280-280.
[3] 贺慷, 杨诚, 李建雄, 罗新贵, 刘存东. 单孔腹腔镜盆腔异位肾输尿管成形术一例报告[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 235-239.
[4] 曾丽华, 林碧云, 蔡敏仪, 易智君, 王晓冰, 陆元志. VHL、PBRM1、BAP1、SETD2 基因在肾透明细胞癌中的表达及临床意义[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(02): 198-204.
[5] 张悦, 张可, 邓锶锶, 向青, 郭亚豪, 曹键, 罗涛, 孟占鳌. 深度学习图像重建三低方案在肾动脉血管成像中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 76-82.
[6] 张浩洋, 凌志新, 许爽, 陈浩, 欧阳骏. 肾肿瘤评分系统的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 88-94.
[7] 孙淼, 吴盛德. 机器人辅助手术治疗小儿肾积水的范围综述[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 95-102.
[8] 梁普照, 吴钰仪, 田振涛. 糖尿病继发左肾周脓肿合并脾脓肿及胸腔积液一例报告[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 116-119.
[9] 朱洪浩, 范新祥. 广东省医学会泌尿外科疑难病例多学科会诊(第18期)——女性尿道癌[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 120-124.
[10] 韦锦焕, 陈旭, 卢军, 陈炜, 罗俊航. 机器人辅助腹腔镜肾部分切除术中逆行切除技术在治疗巨大复杂肾癌中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 27-30.
[11] 叶照华, 李志雄, 罗杰鑫, 刘绍虔, 李牧, 米其武. 输尿管脱套技术在腹腔镜无功能重度积水重复上位半肾切除术中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 47-52.
[12] 高晓峰, 朱士博, 周锐, 唐向亮, 束方鹏, 赵天鑫, 贾炜, 刘国昌, 伏雯. 吲哚菁绿荧光导航在儿童肾盂成形术后再梗阻中的初步应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 31-35.
[13] 唐敏英, 邬绿莹, 陈津, 路君, 吴仲秋. 肾移植术后BKV 肾病免疫细胞浸润及关键基因分析[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(01): 12-19.
[14] 徐琳, 姚东升, 周奕菁, 黄迪. LncRNA NEAT1/miR-129-5p 轴通过调控Wnt/β-catenin 通路活化参与LPS 诱导的肾小管上皮细胞损伤[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(01): 41-50.
[15] 马强. 衰弱和肌少症对肾功能评估的影响及干预策略[J/OL]. 中华肾病研究电子杂志, 2025, 14(01): 60-60.
阅读次数
全文
0
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 0


摘要
14
最新录用 在线预览 正式出版
0 0 14
  来源 本网站 其他网站
  次数 1 13
  比例 7% 93%